GB, Cad, RRM and others-
The Teneo Touch appears larger in size and with Regeneron and Sanofi that dupilumab has many potential indications and so the TT may have been developed to take numerous drug containers and also allow for ease of use for dexterity impaired patients with minimal changes.
Just speculation and IMO
- Forums
- ASX - By Stock
- UNS
- Co. Website.
Co. Website., page-44
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UNS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online